Canine Biologics

We provide highly specialized, evidence-based nutrition to dogs battling cancer.

Print
Claim My Business
Form C
View on Netcapital
Security Type
Common Stock
Min Investment
$100
Location
DENVER, CO
Offering Date
September 09, 2021
Expected Close Date
April 30, 2022
Target Raise
$50.00K-$1.07M
Security Price
$1
Valuation
$6,123,284
Website
caninebiologics.com
Number of Employees
5
Cash
$98,886
Revenue
$5,823
Short Term Debt
$33,296
Cost of Goods
$5,650
Long Term Debt
$0
Net Income
$-353,517

Company Description

Sadly, around 6 million dogs develop cancer every year in the U.S. and Canada
[1]. Canine Biologics offers the optimal nutrition they need for their best quality of life. Pet parents and veterinarians finally have an enhanced, integrated solution specifically designed to help their best furry friend battle cancer.

The diagnosis is devastating, but it doesn’t have to mean that a dog’s best days are over. Canine Biologics was founded because we believe that dogs with cancer can, with the proper support, continue to have the energy and vitality to run, play, and love as they always have as they battle this devastating disease.

introduction
Amount Raised : $39,904
Reveal the Score by Voting
＿
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
ⓘ
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
ⓘ
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
ⓘ
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
ⓘ
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

Common stock is a security that represents ownership in a corporation.

Research Reports

No reports have been submitted

Become a Reporter
Read Our Research Disclaimer

0 Comments

Post Comment